RT Book, Section
A1 Manga, Pravin
A1 McCutcheon, Keir
A1 Tsabedze,  Nqoba
A2 Fuster, Valentin
A2 Narula, Jagat
A2 Vaishnava, Prashant
A2 Leon, Martin B.
A2 Callans, David J.
A2 Rumsfeld, John
A2 Poppas, Athena
SR Print(0)
ID 1191381108
T1 Cardiovascular Disease in Patients with HIV
T2 Fuster and Hurst's The Heart, 15e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264257560
LK accesscardiology.mhmedical.com/content.aspx?aid=1191381108
RD 2022/07/03
AB Chapter  SummaryThis  chapter  focuses  on  current  understanding  of  the  pathogenesis  and  risk  factors  associated  with  heart  disease  in  individuals  with  human  immunodeficiency  virus  (HIV)  infection,  and  discusses  relevant  advances  in  diagnosis  and  management.  Heart  disease  associated  with  HIV  infection  encompasses  a  broad  range  of  manifestations;  infection  with  HIV  may  lead  to  involvement  of  the  pericardium,  myocardium,  coronary  arteries,  cardiac  valves,  pulmonary  vasculature,  as  well  as  the  systemic  vasculature  (see  Fuster  and  Hurst’s  Central  Illustration).  Depending  on  the  level  of  viral  suppression,  patients  may  present  with  features  of  pericardial  effusion,  cardiomyopathy,  ischemic  heart  disease,  diastolic  left  ventricular  dysfunction,  pulmonary  arterial  hypertension,  infective  endocarditis,  and  manifestations  of  thrombotic  events  in  the  systemic  or  venous  circulation.  The  availability  of  healthcare  resources  and  combined  antiretroviral  therapy  has  had  a  major  impact  on  both  the  prevalence  and  severity  of  cardiovascular  disease  as  well  as  on  short-  and  long-term  outcomes.  As  many  HIV  infected  persons  are  living  much  longer,  the  role  of  the  cardiovascular  specialist  is  increasingly  important  in  the  prevention  and  management  of  various  cardiac  manifestations  that  may  develop  in  such  patients.